Trial Profile
Cortical Excitability in Neuropathic Pain: Investigating the combined effects of pregabalin and repetitive transcranial magnetic stimulation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Pharmacodynamics
- 10 Dec 2015 Planned End Date changed from 30 Nov 2015 to 28 Nov 2015 according to United Kingdom Clinical Research Network.
- 10 Dec 2015 Status changed from recruiting to active, no longer recruiting according to United Kingdom Clinical Research Network.
- 01 Dec 2015 Accrual to date is 225% according to United Kingdom Clinical Research Network